Werewolf Therapeutics Inc (HOWL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is leveraging its proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Its most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors.The company is continuing preclinical studies for both WTX-124 and WTX-330 and expect to advance each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor.

Data as of 2021-10-09 11:04:06 -0400
Market Cap438.327 Million Shares Outstanding27.568 Million Avg 30-day Volume16.758 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.26 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low23.99 / 11.23 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

View recent insider trading info

Funds Holding HOWL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HOWL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KARUNATILAKE CHULANI CHIEF TECHNOLOGY OFFICER

  • Officer
272,000 2021-07-01 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
4,291,881 2021-06-14 2

SHERMAN MICHAEL A.

  • Director
23,200 2021-05-27 2

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2021-05-04 1

GADICKE ANSBERT

MPM ONCOLOGY INNOVATIONS FUND LP

UBS ONCOLOGY IMPACT FUND L.P.

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

MPM ONCOLOGY IMPACT MANAGEMENT LP

MPM ONCOLOGY INNOVATIONS FUND GP LLC

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

  • 10% Owner
18,038,516 2021-05-04 1

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
No longer subject to file 2021-05-04 1

ARKIN BIO VENTURES 2 L.P.

ARKIN BIO VENTURES GPGP LTD.

ARKIN MOSHE

  • 10% Owner
No longer subject to file 2021-05-04 1

MPM BIOVENTURES 2014, L.P.

MPM BIOVENTURES 2014 (B), L.P.

MPM BIOVENTURES 2014 LLC

MPM BIOVENTURES 2014 GP LLC

FOLEY TODD

MPM ASSET MANAGEMENT INVESTORS BV2014 LLC

  • 10% Owner
8,548,667 2021-05-04 1

SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

SPHERA GLOBAL HEALTHCARE GP LTD.

SPHERA FUNDS MANAGEMENT LTD.

  • 10% Owner
No longer subject to file 2021-05-04 1

LONGWOOD FUND III GP, LLC

LONGWOOD FUND III, L.P.

  • 10% Owner
No longer subject to file 2021-05-04 1

UPMC

  • 10% Owner
No longer subject to file 2021-05-04 1

TAIHO VENTURES LLC

  • 10% Owner
No longer subject to file 2021-05-04 1

EVNIN LUKE

  • Director
  • 10% Owner
23,200 2021-04-30 2

MORRISON BRIGGS

  • Director
23,200 2021-04-30 1

DIROCCO DEREK

  • Director
23,200 2021-04-30 1

TROST TIMOTHY W. CHIEF FINANCIAL OFFICER

  • Officer
302,568 2021-02-12 1

LAZARUS ALON

  • Director
  • 10% Owner
2,069,834 2020-12-23 1

ASANUMA SAKAE

  • Director
  • 10% Owner
2,068,909 2020-12-23 1

HICKLIN DANIEL J SEE REMARKS

  • Officer
  • Director
  • 10% Owner
882,793 2020-12-08 1

LEONARD REID CHIEF OPERATING OFFICER

  • Officer
126,474 2020-12-08 1

SEIDEL-DUGAN CYNTHIA CHIEF SCIENTIFIC OFFICER

  • Officer
157,071 2020-12-08 1

ISAACS RANDI CHIEF MEDICAL OFFICER

  • Officer
373,960 2020-11-09 1

LUBMAN ELLEN CHIEF BUSINESS OFFICER

  • Officer
312,767 2020-08-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 22:15:04 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 21:45:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 21:15:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 20:45:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 20:15:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 19:45:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 19:15:04 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 18:45:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 18:15:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 17:45:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 17:15:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 16:45:03 UTC -14.8349 14.9049 550000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 16:15:03 UTC -14.8349 14.9049 250000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 15:45:03 UTC -14.8349 14.9049 30000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 15:15:03 UTC -14.8349 14.9049 30000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 14:45:02 UTC -14.8349 14.9049 30000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 14:15:03 UTC -14.8349 14.9049 30000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 13:45:03 UTC -14.8349 14.9049 30000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 13:15:03 UTC -14.8349 14.9049 30000
WEREWOLF THERAPEUTICS INC HOWL 2021-10-15 12:45:03 UTC -14.8349 14.9049 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund HOWL -1079.0 shares, $-18817.76 2021-06-30 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund HOWL -59.0 shares, $-1027.78 2021-07-31 N-PORT

Elevate your investments